D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
Aurora
AUR
$11.7B
| $121M | 0.07% |
29,260,125
-5,199,718
| -15% | -$23M |
2022 Q2
15 quarters
|
|
302
Salesforce
CRM
$189B
| $121M | 0.07% |
645,704
-133,599
| -17% | -$27.7M |
2013 Q2
51 quarters
|
|
303
CALL
Verizon
VZ
$173B
| $120M | 0.07% |
2,397,300
-1,308,500
| -35% | -$60.6M |
2021 Q2
19 quarters
|
|
304
Elevance Health
ELV
$89.5B
| $119M | 0.07% |
405,992
-86,004
| -17% | -$28.3M |
2014 Q4
45 quarters
|
|
305
PUT
Reddit
RDDT
$30.8B
| $119M | 0.07% |
882,300
-59,500
| -6% | -$10.1M |
2024 Q4
5 quarters
|
|
|
DOCU
306
DocuSign
DOCU
$13.3B
| $119M | 0.07% |
+2,501,812
| New | +$128M |
2026 Q1
0 quarters
|
|
|
NEE.PRS
307
NextEra Energy 7.299% Corporate Units
NEE.PRS
$1.98B
| $118M | 0.07% |
2,081,000
+475,000
| +30% | +$26.2M |
2024 Q2
7 quarters
|
|
308
PUT
Dow Inc
DOW
$20.5B
| $117M | 0.07% |
2,819,900
-758,600
| -21% | -$24.1M |
2022 Q2
15 quarters
|
|
309
Dynatrace
DT
$18.4B
| $117M | 0.07% |
3,160,367
+1,561,358
| +98% | +$59.7M |
2025 Q4
1 quarter
|
|
310
CVS Health
CVS
$110B
| $116M | 0.07% |
1,617,522
+542,634
| +50% | +$41.8M |
2014 Q2
47 quarters
|
|
311
CALL
Moderna
MRNA
$89.8B
| $115M | 0.07% |
2,267,800
+401,200
| +21% | +$18.7M |
2020 Q2
23 quarters
|
|
|
JBS
312
JBS N.V.
JBS
$42.7B
| $115M | 0.07% |
6,389,933
-815,695
| -11% | -$12.7M |
2025 Q2
3 quarters
|
|
313
Intuitive Machines
LUNR
$2.13B
| $114M | 0.07% |
6,162,811
+2,569,287
| +71% | +$47.4M |
2024 Q3
6 quarters
|
|
314
CALL
ASML
ASML
$684B
| $114M | 0.07% |
86,100
+6,900
| +9% | +$9.46M |
2019 Q3
26 quarters
|
|
315
Realty Income
O
$51.3B
| $113M | 0.07% |
1,850,345
+1,678,865
| +979% | +$105M |
2024 Q4
5 quarters
|
|
316
PUT
Seagate
STX
$178B
| $113M | 0.07% |
287,800
-22,100
| -7% | -$8.43M |
2013 Q2
51 quarters
|
|
317
PUT
Nike
NKE
$51.6B
| $113M | 0.07% |
2,134,300
-81,000
| -4% | -$4.91M |
2020 Q1
24 quarters
|
|
318
CALL
Toronto Dominion Bank
TD
$188B
| $112M | 0.07% |
1,200,000
-527,500
| -31% | -$50.2M |
2021 Q2
19 quarters
|
|
319
PTC Therapeutics
PTCT
$5.4B
| $112M | 0.07% |
1,640,381
-104,610
| -6% | -$7.41M |
2016 Q2
39 quarters
|
|
320
Vertex Pharmaceuticals
VRTX
$129B
| $111M | 0.07% |
+248,960
| New | +$116M |
2026 Q1
0 quarters
|
|
321
Regal Rexnord
RRX
$11B
| $111M | 0.07% |
593,462
+231,253
| +64% | +$43M |
2024 Q2
7 quarters
|
|
322
W.W. Grainger
GWW
$60.8B
| $111M | 0.07% |
101,750
-152,893
| -60% | -$167M |
2016 Q1
40 quarters
|
|
|
ORCL.PRD
323
Oracle Corp Preferred Stock Series D
ORCL.PRD
| $111M | 0.07% |
+2,421,500
| New | +$114M |
2026 Q1
0 quarters
|
|
324
Coca-Cola
KO
$379B
| $111M | 0.07% |
1,458,989
-1,841
| -0.1% | -$139K |
2013 Q2
51 quarters
|
|
|
Q
325
Qnity Electronics Inc
Q
$26.5B
| $111M | 0.07% |
960,820
-2,623,376
| -73% | -$279M |
2025 Q4
1 quarter
|
|
Similar funds
D.E. Shaw & Co's Q1 2026 Portfolio in Review
As of Q1 2026, D.E. Shaw & Co held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in Venture Global Inc worth $211M.
- D.E. Shaw & Co's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- D.E. Shaw & Co added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- D.E. Shaw & Co opened 685 new positions and closed 756 in Q1 2026.
- D.E. Shaw & Co's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.